Exploring Novel Therapeutics for Hepatocellular Carcinoma:from Molecule- to Metabolism-targeted Therapy
博士 === 國立臺灣大學 === 毒理學研究所 === 101 === Hepatocellular carcinoma (HCC) is associated with a high mortality worldwide as well as in Taiwan. Sorafenib, a molecular targeted therapy inhibiting angiogenesis and Raf-1, is the only drug approved for the treatment of advanced HCC because of its survival be...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2013
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/cc2h8d |